Showing results (291-300 of 307) with videos related to

Sort By:
Pageof 31
British Journal of Cancer|September 28, 2006
Maternal hemoglobin concentration during pregnancy and risk of infant leukaemia: a children's oncology group studyA M Peters, C K Blair, M R Verneris, et al.
Epidemiology (Cambridge, Mass.)|January 1, 1994
Does body fat distribution promote familial aggregation of adult onset diabetes mellitus and postmenopausal breast cancer?T A Sellers, J M Sprafka, S M Gapstur, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|October 13, 2016
Single-dose systemic methotrexate vs expectant management for treatment of tubal ectopic pregnancy: a placebo-controlled randomized trialD Jurkovic, M Memtsa, E Sawyer, et al.
Carcinogenesis|October 1, 1992
DNA adducts and induction of sister chromatid exchanges in the rat following benzo[b]fluoranthene administrationJ A Ross, G B Nelson, K L Holden, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|December 24, 1997
National cancer clinical trials: children have equal access; adolescents do notW A Bleyer, H Tejeda, S B Murphy, et al.
British Journal of Cancer|July 31, 2008
Childhood cancer in the offspring born in 1921-1984 to US radiologic technologistsK J Johnson, B H Alexander, M M Doody, et al.
British Journal of Cancer|November 3, 2004
Childhood and maternal infections and risk of acute leukaemia in children with Down syndrome: a report from the Children's Oncology GroupK N Canfield, L G Spector, L L Robison, et al.
British Journal of Cancer|January 28, 2010
Plasma MIC-1 correlates with systemic inflammation but is not an independent determinant of nutritional status or survival in oesophago-gastric cancerR J E Skipworth, D A C Deans, B H L Tan, et al.
Chemical Research in Toxicology|June 21, 2001
An evaluation of the mutagenicity, metabolism, and DNA adduct formation of 5-nitrobenzo[b]naphtho[2,1-d]thiopheneL C King, M J Kohan, L Brooks, et al.
The Journal of Dermatological Treatment|November 23, 2020
Baricitinib improves symptoms in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: patient-reported outcomes from two randomized monotherapy phase III trialsK Reich, A M DeLozier, F P Nunes, et al.
Pageof 31